Oxidative stress and chronic inflammation are recognized as significant contributors to cancer development and progression. Dihydromyricetin (DHM), a potent natural flavonoid, offers a dual benefit by actively scavenging reactive oxygen species (ROS) and exhibiting anti-inflammatory properties. NINGBO INNO PHARMCHEM CO.,LTD. discusses DHM's role in cellular protection against these cancer-promoting factors.

DHM's antioxidant capacity is a key aspect of its anti-cancer effect. By neutralizing excess ROS, DHM prevents oxidative damage to cellular components, including DNA. This protective action can inhibit the initiation and promotion phases of carcinogenesis, where ROS often play a critical role in driving mutations and uncontrolled cell growth.

Furthermore, DHM demonstrates anti-inflammatory effects by modulating key signaling pathways, such as NF-κB and by reducing the production of pro-inflammatory cytokines like TNF-α and IL-6. Chronic inflammation creates a microenvironment that can fuel tumor growth and metastasis. By mitigating inflammation, DHM helps to create a less conducive environment for cancer progression.

The combined actions of ROS scavenging and anti-inflammatory effects make DHM a valuable natural compound for cancer prevention and therapy. Its ability to address underlying cellular mechanisms that promote cancer development highlights its therapeutic potential. NINGBO INNO PHARMCHEM CO.,LTD. is a trusted supplier of pure DHM, supporting research into these crucial protective and therapeutic functions.